ARTICLE | Distillery Therapeutics
Microbial polyketide for relapsing C. difficile infection
July 18, 2023 8:47 PM UTC
The polyketide chlorotonil A, derived from the myxobacterium Sorangium cellulosum, could help treat Clostridium difficile and prevent relapse by preventing spore outgrowth and selectively targeting Gram-positive bacteria, preserving the composition and colonization resistance of the host microbiome.
In a panel of C. difficile strains resistant to several antibiotics, the compound inhibited bacterial growth with a minimum inhibitory concentration and a minimum bactericidal concentration comparable to or lower than vancomycin's. ...